Characterization of the α 1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter

British Journal of Pharmacology

Volumn 155, Issue 1, 2008, Pages 110-117

  Mills, K A ^a   Hausman, N ^b   Chess Williams, R ^a  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

adrenoceptor; Internal anal sphincter; Pig incontinence; Receptor classification

Indexed keywords

5 CHLORO N [2 (2 CYCLOPROPYLMETHOXYPHENOXY)ETHYL] ALPHA,ALPHA DIMETHYL 1H INDOLE 3 ETHANAMINE; 5 METHYL 3 [3 [4 [2 (2,2,2 TRIFLUOROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 1H PYRIMIDINE 2,4 DIONE; 5 METHYL 3 [3 [4 [2 (2,2,2 TRIFLUROETHOXY)PHENYL] 1 PIPERAZINYL]PROPYL] 2,4(1H,3H) PYRIMIDINEDIONE; 5 METHYLURAPIDIL; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ALPHA 1 ADRENERGIC RECEPTOR; N [5 (4,5 DIHYDRO 1H IMIDAZOL 2 YL) 5,6,7,8 TETRAHYDRO 2 HYDROXY 1 NAPHTHYL]METHANESULFONAMIDE; NORADRENALIN; PHENYLEPHRINE; PIPERAZINE DERIVATIVE; PRAZOSIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ADRENERGIC RECEPTOR ALPHA(1A); ADRENERGIC RECEPTOR ALPHA(1L); ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL TISSUE; ANUS SPHINCTER; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE CONTRACTION; SWINE; ANAL CANAL; ANIMAL; DOSE RESPONSE; DRUG EFFECT; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANAL CANAL; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MUSCLE CONTRACTION; RECEPTORS, ADRENERGIC, ALPHA-1; SWINE;

EID: 50249101593     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.217     Document Type: Article

References (35)

1. Aggestrup S, Uddman R, Jensen SL, Hakanson R, Sundler F, Schaffalitzky de Muckadell O et al. (1986). Regulatory peptides in lower esophageal sphincter of pig and man. Dig Dis Sci 31: 1370-1375.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1-S209.
3. Arunlakshana O, Schild HO (1959). Some quantitative uses of drug antagonists. B J Pharmacol Chemother 14: 48-58.
4. Badvie S, Andreyev H (2005). Topical phenylephrine in the treatment of radiation-induced faecal incontinence. Clin Oncol (R Coll Radiol) 17: 122-126.
5. Brown D, Timmermans J (2004). Lesson from the porcine enteric nervous system. Neurogastroenterol Motil 16: 50-54.
6. Buckner SA, Oheim KM, Morse PA, Knepper SM, Hancock AA (1996). Alpha 1-adrenoceptor-induced contractility in rat aorta is mediated by the alpha 1D subtype. Eur J Pharmacol 267: 241-248.
7. Burt RP, Chapple CR, Marshall I (1995). Evidence for a functional alpha 1A- (alpha 1C-) adrenoceptor mediating contraction of the rat epididymal vas deferens and an alpha 1B-adrenocepor mediating contraction of the rat spleen. Br J Pharmacol 115: 467-475.
8. Carapeti E, Kamm M, Evans B, Phillips R (1999). Topical phenylephrine increases anal sphincter resting pressure. Br J Surg 86: 267-270.
9. Carapeti EA, Kamm MA, Nicholls RJ, Phillips RK (2000a). Randomized, controlled trial of topical phenylephrine for fecal incontinence in patients after ileoanal pouch construction. Dis Colon Rectum 43: 1059-1063.
10. Carapeti EA, Kamm MA, Phillips RK (2000b). Randomized controlled trial of topical phenylephrine in the treatment of faecal incontinence. Br J Surg 87: 38-42.
11. Cheetham MJ, Kamm MA, Phillips RK (2001). Topical phenylephrine increases anal canal resting pressure in patients with faecal incontinence. Gut 48: 356-359.
12. 1-adrenoceptors in human prostate: implications for adrenoceptor classification. Mol Pharmacol 49: 209.
13. Ford AP, Daniels DV, Chang DJ, Gever JR, Jasper JR, Lesnick JD et al. (1997). Pharmacological pleitropism of the human recombinant alpha1A-adrenoceptor: implications for alpha1-adrenoceptor classification. Br J Pharmacol 121: 1127-1135.
14. Goetz AS, King HK, Ward SD, True TA, Rimele TJ, Saussy DL (1995). BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors. Eur J Pharmacol 272: R5-R6.
15. Hanft G, Gross G (1989). Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists. Br J Pharmacol 97: 691-700.
16. Kalantar J, Howell S, Talley J (2002). Prevalence of faecal incontinence and associated risk factors. An underdiagnosed problem in the Australian community? Medical Journal of Australia 176: 54-57.
17. Kenny BA, Chalmers DH, Philpott PC, Naylor AM (1995). Characterization of an alpha 1D-adrenoceptor mediating the contractile response of rat aorta to noradrenaline. Br J Pharmacol 115: 981-986.
18. Knepper SM, Buckner SA, Brune ME, Debernardis JF, Meyer MD, Hancock AA (1995). A-61630, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype. J Pharmacol Exp Ther 274: 97-103.
19. Langer SZ (1999). History and nomenclature of alpha1-adrenoceptors. Eur Urol 36 (Suppl. 1): 2-6.
20. Lestar B, Pennickx F, Kerremans R (1989). The composition of anal basal pressure. An in vivo and in vitro study in man. Int J Colorectal Dis 4: 118-122.
21. Mackenzie JF, Daly CJ, Pediani JD, McGrath JC (2000). Quantitative imaging in live human cells reveals intracellular alpha(1)-adrenoceptor ligand-binding sites. J Pharmacol Exp Ther 294: 434-443.
22. 1A-adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053. Br J Pharmacol 119: 407-415.
23. Mellgren A, Jensen LL, Zetterstrom JP, Wong WD, Hofmeister JH, Lowry AC (1999). Long-term cost of faecal incontinence secondary to obstetric injuries. Dis Colon Rectum 42: 857-865.
24. Michel MC, Insel PA (1994). Comparison of cloned and pharmacologically defined rat tissue alpha 1-adrenoceptor subtypes. Naunyn-Schmiedeberg's Arch Pharmacol 352: 1-10.
25. Michel MC, Kenny B, Schwinn DA (1995). Classification of alpha 1-adrenoceptor subtypes. Naunyn Schmiedebergs Arch Pharmacol 352: 1-10.
26. Muramatsu I, Kigoshi S, Oshita M (1990). Two distinct alpha 1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta. Br J Pharmacol 101: 662-666.
27. Noble AJ, Chess-Williams R, Couldwell C, Furukawa K, Uchyiuma T, Korstanje C et al. (1997). The effects of tamsulosin, a high affinity antagonist at functional alpha 1A- and alpha 1D-adrenoceptor subtypes. Br J Pharmacol 120: 231-238.
28. Rattan S (2005). The internal anal sphincter: regulation of smooth muscle tone and relaxation. Neurogastroenterol Motil 17 (Suppl. 1): 50-59.
29. Sand J, Arvola P, Jantti V, Oja S, Singaram C, Baer G et al. (1997). The inhibitory role of nitric oxide in the control of porcine and human sphincter of Oddi activity. Gut 41: 375-380.
30. Shibamoto T, Chakder S, Rattan S (1994). Role of hypogastric nerve activity in opossum internal anal sphincter function: influence of surgical and chemical denervation. J Pharmacol Exp Ther 271: 277-284.
31. Smith DA (1995). The current state of continence care and treatment. IDEA 95 Conference papers; INDA 25-27, Philadelphia, PA.
32. Stam WB, Van der Graaf PH, Saxena PR (1999). Analysis of alpha 1L-adrenoceptor pharmacology in rat small mesenteric artery. Br J Pharmacol 127: 661-670.
33. Williams TJ, Blue DR, Daniels DV, Davis B, Elworthy T, Gever JR et al. (1999). In vitro alpha 1-adrenoceptor pharmacology of RO70-0004 and RS-100329, novel alpha 1A-adrenoceptor selective antagonists. Br J Pharmacol 127: 252-258.
34. Yamato S, Rattan S (1990). Role of alpha adrenoceptors in opossum internal anal sphincter. J Clin Invest 86: 424-429.
35. Zhong H, Minneman KP (1999). Alpha1-adrenoceptor subtypes. Eur J Pharmacol 375: 261-276.